CF PharmTech, Inc. (stock code 02652) disclosed that on 4 February 2026, 8,500 ordinary shares were repurchased at a volume-weighted average price of HKD 34.7706. The repurchased shares represent approximately 0.0028% of the total number of issued shares (excluding treasury shares) as of the preceding day.
Following this repurchase, the company recorded 302,022,586 issued shares (excluding treasury shares) and a total of 201,000 treasury shares as of 4 February 2026. The aggregate price paid for the 8,500 repurchased shares amounted to HKD 295,550. The repurchase was executed in accordance with the previously granted mandate dated 16 December 2025, under which up to 30,222,358 shares were authorized for repurchase.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.